Cidofovir added to highly active antiretroviral therapy in AIDS-associated progressive multifocal leukoencephalopathy

AIDS

Volumn 15, Issue 6, 2001, Pages 809-

  Herrero Romero, M ^a   Cordero, E ^a   Lopez Cortes L F ^a   De Alarcon A ^a   Pachon J ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CIDOFOVIR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIVIRAL ACTIVITY; ARTICLE; BRAIN BIOPSY; CAUSE OF DEATH; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG USE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; JC VIRUS; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPOVAVIRUS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SURVIVAL; VIRUS DETECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; CYTOSINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS;

EID: 0035853431     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200104130-00023     Document Type: Article

References (6)

1. The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infection
2. 2.5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy
3. Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy
4. Activities of various compounds against murine and primate polyomaviruses
5. Remission of AIDS-associated progressive multifocal leukoencephalopathy after cidofovir therapy
6. Monitoring the response of AIDS-related progressive multifocal leukoencephalopathy to HAART and cidofovir by PCR for JC virus DNA in the CSF